Education
About Us
Working with TipRanks
Follow Us
N4 Pharma PLC (GB:N4P)
LSE:N4P
N4P Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.35p - 0.80p
Previous CloseN/A
Volume555.10K
Average Volume (3M)1.44M
Market Cap
£7.24M
Enterprise ValueN/A
Total Cash (Recent Filing)£1.20M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Sep 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding832,280,330
10 Day Avg. Volume570,823
30 Day Avg. Volume1,442,171
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
N4 Pharma News
PremiumCompany Announcements
N4 Pharma Reports Strong Progress and Financial Results for 2024
PremiumCompany Announcements
N4 Pharma Announces Change in Voting Rights Structure
PremiumCompany Announcements
N4 Pharma Announces Transfer of Voting Rights
PremiumCompany Announcements
N4 Pharma’s Nuvec® Shows Promising Results in IBD Study
PremiumCompany Announcements
N4 Pharma Plc Announces Change in Major HoldingsPremiumCompany Announcements
N4 Pharma PLC Announces Change in Voting RightsPremiumCompany Announcements
N4 Pharma Announces Change in Major ShareholdingsN4P FAQ
What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.35p and its highest was 0.80p in the past 12 months.
What is N4 Pharma PLC’s market cap?
N4 Pharma PLC’s market cap is £7.24M.
When is N4 Pharma PLC’s upcoming earnings report date?
N4 Pharma PLC’s upcoming earnings report date is Sep 17, 2025 which is in 101 days.
How were N4 Pharma PLC’s earnings last quarter?
N4 Pharma PLC released its earnings results on Jun 06, 2025. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is N4 Pharma PLC overvalued?
According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued.
Does N4 Pharma PLC pay dividends?
N4 Pharma PLC does not currently pay dividends.
What is N4 Pharma PLC’s EPS estimate?
N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma PLC have?
N4 Pharma PLC has 832,280,330 shares outstanding.
What happened to N4 Pharma PLC’s price movement after its last earnings report?
N4 Pharma PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of N4 Pharma PLC?
Currently, no hedge funds are holding shares in GB:N4P
Company Description
N4 Pharma PLC
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Technical Analysis
Allergy Therapeutics
―
Chill Brands Group PLC
―
Provexis
―
Shield Therapeutics
―
Celadon Pharmaceuticals PLC
―